Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenetic study of atypical antipsychotic drug response: involvement of the norepinephrine transporter gene.

American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics - 5 Jun 2008

Méary A, Brousse G, Jamain S, Schmitt A, Szöke A, Schürhoff F, Gavaudan G, Lancon C, Macquin-Mavier I, Leboyer M, Llorca P M

Abstract excerpt

The identification of genetic factors underlying individual differences in antipsychotic drug response is of major interest. We investigated the involvement of two norepinephrine transporter gene polymorphisms in response to antipsychotics, comparing patients with strong and weak response to olanzapine and risperidone. We prospectively assessed short-term drug response in 75 Caucasian schizophrenic patients...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antipsychotic Agents
Share to Benzodiazepines

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Norepinephrine Plasma Membrane Transport Proteins

Share to Olanzapine

Share to Pharmacogenetics

Share to Psychiatric Status Rating Scales

Share to Risperidone

Share to Schizophrenia

Source

Identifiers

PMID: 18085566
DOI: 10.1002/ajmg.b.30635

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenetic study of atypical antipsychotic drug response: involvement of the norepinephrine transporter gene.PMID 18085566Read ↗

The Pharmacogenetics of Symptom Response to Antipsychotic DrugsSemantic proximity Read ↗

The —1019 C/G polymorphism of the 5-HT1A receptor gene is associated with negative symptom response to risperidone treatment in schizophrenia patientsSemantic proximity Read ↗

Genomics and the future of pharmacotherapy in psychiatrySemantic proximity Read ↗

Polymorphisms of the 5-HT2A receptor gene and clinical response to olanzapine in paranoid schizophrenia.Semantic proximity Read ↗

Contribution of allelic variations in transporters to the phenotype of drug response.Semantic proximity Read ↗

Serotonin transporter polymorphisms and early response to antipsychotic treatment in first episode of psychosis.Semantic proximity Read ↗

COMT Val158Met and 5-HT1A-R -1019 C/G polymorphisms: effects on the negative symptom response to clozapine.Semantic proximity Read ↗

5-HT2A receptor promoter polymorphism, -1438G/A and negative symptom response to olanzapine in schizophrenia.Semantic proximity Read ↗

Evidence for a SULT4A1 haplotype correlating with baseline psychopathology and atypical antipsychotic response.Semantic proximity Read ↗

The identification of novel genetic variants associated with antipsychotic treatment response outcomes in first-episode schizophrenia patients.Semantic proximity Read ↗

Pharmacogenetics of treatment in first-episode schizophrenia: D3 and 5-HT2C receptor polymorphisms separately associate with positive and negative symptom response.Semantic proximity Read ↗

Negative symptoms of schizophrenia could explain discrepant data on the association between the 5-HT2A receptor gene and response to antipsychotics.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.